Value Hive
Value Hive

Aaron Edelheit: Dumpster Diving in Cannabis

I hope you guys enjoy my podcast with Aaron Edelheit on the Cannabis industry. I had Aaron on the podcast two years ago to dive deep into the cannabis space. Since then, the industry has done nothing but incinerate investor capital. And that's precisely why I wanted to interview Aaron. I love h

Featured Speakers

Brandon Beylo HostAaron Edelheit Guest

Topics Discussed

Episode Summary

Executive Summary: The episode is a deep dive into cannabis investing with Aaron Edelheit, who explains why he stayed in the sector through the brutal 2022 downturn, how he shifted from betting on large MSOs to focusing on operational excellence in cultivation, and why he now sees hemp beverages as a major emerging opportunity. The conversation centers on regulation, liquidity, valuation discipline, and finding mispriced businesses in a hated market.

Main Topics: Why cannabis remained an investable opportunity despite the 2022 collapse (Priority: 5/5): Aaron argues the sector was devastated by falling liquidity, stalled regulation, and slowing growth, but that the destruction created opportunity for patient investors willing to do deep fundamental work. Thesis shift from large MSOs to operationally excellent cultivators (Priority: 5/5): He explains that his original belief in scale and vertical integration was wrong; the winners are companies with clear cost advantages, focused strategy, and strong execution. Glass House and Grown Rogue as proof of operating edge (Priority: 5/5): Aaron uses these two holdings to illustrate how greenhouse efficiency, cultivation discipline, and niche positioning can create durable margins even in brutal pricing environments. Regulation, rescheduling, and capital structure strategy (Priority: 4/5): He expects federal reform to eventually unlock the sector, but says he is not trading the headline. Instead, he moved up the capital structure into debt and convertible instruments to get paid while waiting. Valuation must be state-specific and grounded in unit economics (Priority: 4/5): Aaron emphasizes that cannabis businesses in different states cannot be valued the same because pricing, regulation, and competitive dynamics vary widely by market. Hemp beverages as the next big cannabis-adjacent opportunity (Priority: 5/5): He highlights explosive early adoption of THC beverages and says he is launching a fund focused on the category, viewing it as potentially the sector’s ‘killer app.’

Key Arguments: The 2022 cannabis drawdown was driven by a combination of liquidity drying up, regulatory disappointment, and slowing growth, which eliminated weak investors and funds but created opportunity for survivors. Aaron’s original thesis on MSOs and scale was flawed because many were built for limited-license land grabs, not operational excellence or resilient unit economics. Cannabis cultivation is not easy; it is a difficult agricultural science where greenhouse design, climate, genetics, and process discipline matter enormously. Glass House demonstrates that greenhouse cultivation can produce strong gross margins and a real cost advantage even as California cannabis prices collapsed. Grown Rogue shows that a focused craft-cultivation model can generate strong EBITDA margins in highly competitive, low-price markets. Cannabis pricing and cash flows differ by state, so New Jersey, Oregon, Massachusetts, and other markets should not be valued using the same framework. Instead of betting on a near-term trading catalyst, Aaron prefers to own businesses with sustainable advantages and get yield through debt and preferred-style exposure. Hemp beverages are emerging as a mainstream consumer product because they are socially acceptable, low-dose, and expanding quickly through liquor stores and other channels. If federal reform stalls and no interstate commerce develops, the sector could remain depressed, but Aaron believes rescheduling is still likely. The industry remains under-researched, which increases the chance of finding mispriced assets for investors willing to do proper diligence.

Data Points: Cannabis fund return in last year: Up 70% - Aaron said his cannabis fund rebounded strongly after the 2022 drawdown. Industry cash crop pricing example: $4,000 per pound to $1,200 per pound - He cited collapsing cannabis pricing in older markets as a key reason prior models broke down. Glass House cultivation gross margin: 61% - Used as evidence that Glass House had a strong cost advantage in cultivation. Grown Rogue EBITDA margin: 34% - Aaron described this as exceptional for a cultivator operating in competitive markets. Grown Rogue production cost: $550 per pound - Estimated cost basis Aaron said the company can achieve for high-quality indoor flower. Grown Rogue Michigan expansion cost: $4 million - He said the company became a top-five indoor flower brand in Michigan after a relatively small investment. Glass House share price bottom: $1.93 - Aaron referenced this as the stock’s low point before recovering toward $7. Air Wellness share move: $4 to $35 to $0.60 to over $3 - Used to illustrate volatility and the sector’s boom-bust behavior. Tilray share move: $300 to $1.91 - Cited as an example of how violent drawdowns have scared investors away. U.S. alcohol market revenue: $260 billion per year - Used in the hemp beverage discussion to show the size of the addressable market. Minnesota liquor store sales from hemp THC beverages: 15% - Aaron highlighted this as evidence of rapid adoption in one state. Minnesota sales figure previously cited: 10% - He said he originally read 10% and then confirmed the number was even higher later. Days of sunshine at Glass House facility: 320 days per year - He noted favorable Santa Barbara-area weather as part of the greenhouse advantage. Average temperature at facility: 72 degrees - Referenced as a key environmental advantage for low-cost cultivation. Potential annual free cash flow for Glass House: $2 to $3 per share - Aaron suggested the company could generate very high free cash flow if fully optimized.

Pivotal Quotes: "the Great replacement" — Aaron Edelheit: His phrase for cannabis replacing more toxic or less desirable consumer substances and behaviors. "the number one rule of fishermen is to fish where the fish are, and the number two rule is not to forget number one" — Aaron Edelheit: He used this Charlie Munger-inspired line to explain why he stayed in cannabis despite widespread capitulation. "I think low-dose beverages, I think, are the killer app" — Aaron Edelheit: He argued hemp THC beverages could be the category’s most important mainstream product.

Implications: The episode suggests cannabis remains a high-risk, high-opportunity market where operational quality matters more than scale. Investors should focus on unit economics, state-by-state pricing, and emerging categories like hemp beverages rather than broad sector narratives.

🔓 Sign Up for Unlimited Episode Search

About Value Hive

Welcome to The Hive! It's nice in here, isn't it? The Hive is a collection of investors, entrepreneurs, thinkers and individuals dedicated to getting a little smarter each day. If you're a fan of value investing, business models, eclectic success and failure stories -- this is your podcast. Our goal is to provide you the highest quality interviews with new twists on old topics. Fresh perspectives on antiquated ideas. Passionate discourse on all things investing. Join us as we strive to improve a little bit each day: https://macro-ops.com/

View all episodes from Value Hive